A landscape of synergistic drug combinations in non-small-cell lung cancer
N. U. Nair, P. Greninger, A. Friedman…·C. H. Benes
The paper identifies synergistic drug combinations in non-small-cell lung cancer cell lines, finding that synergy often arises from sensitizing resistant models through dual pathway targeting.